Infections in a surgical intensive care unit of a university hospital in Greece

被引:32
作者
Markogiannakis, Haridimos [1 ]
Pachylaki, Nikoleta [1 ]
Samara, Eleni [1 ]
Kalderi, Melpomeni [2 ]
Minettou, Maria [2 ]
Toutouza, Marina [2 ]
Toutouzas, Konstantinos G. [1 ]
Theodorou, Dimitrios [1 ]
Katsaragakis, Stilianos [1 ]
机构
[1] Univ Athens, Surg Intens Care Unit, Dept Propaedeut Surg 1, Hippokrate Hosp,Athens Med Sch, Athens 11527, Greece
[2] Hippokrate Hosp, Dept Microbiol, Athens, Greece
关键词
Surgical intensive care unit; Infections; Microorganisms; Multi-drug resistance; Morbidity; Mortality; Ventilator-associated pneumonia; Enterococcus faecium; GRAM-NEGATIVE BACILLI; NOSOCOMIAL INFECTIONS; STAPHYLOCOCCUS-AUREUS; CONSENSUS CONFERENCE; ACQUIRED INFECTIONS; CDC DEFINITIONS; ORGAN FAILURE; RISK-FACTORS; SEPSIS; SUSCEPTIBILITY;
D O I
10.1016/j.ijid.2008.05.1227
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to evaluate the clinical and microbiological characteristics of the patients who developed an infection in our surgical intensive care unit (SICU). Methods: This was a prospective study of all patients who sustained an ICU-acquired infection from 2002 to 2004. Results: Among 683 consecutive SICU patients, 123 (18.0%) developed 241 infections (48.3 infections per 1000 patient-days). The mean age of patients was 66.7 +/- 3.8 years, the mean APACHE II score (acute physiology and chronic health evaluation) on SICU admission was 18.2 +/- 2.4, and the mean SOFA score (sepsis-related organ failure assessment) at the onset of infection was 8.8 +/- 2. Of the study patients, 51.2% were women. Infections were: bloodstream (36.1%), ventilator-associated pneumonia (VAP; 25.3%, 20.3/1000 ventilator-days), surgical site (18.7%), central venous catheter (10.4%, 7.1/1000 central venous catheter-days), and urinary tract infection (9.5%, 4.6/1000 urinary catheter-days). The most frequent microorganisms found were: Acinetobacter baumannii (20.3%), Pseudomonas aeruginosa (15.7%), Candida albicans (13.2%), Enterococcus faecalis (10.4%), Klebsiella pneumoniae (9.2%), Enterococcus faecium (7.9%), and Staphylococcus aureus (6.7%). High resistance to the majority of antibiotics was identified. The complication and mortality rates were 58.5% and 39.0%, respectively. Multivariate analysis identified APACHE 11 score on admission (odds ratio (OR) 4.63, 95% confidence interval (CI) 2.69-5.26, p = 0.01), peritonitis (OR 1.85, 95% CI 1.03-3.25, p = 0.03), acute pancreatitis (OR 2.27, 95% CI 1.05-3.75, p = 0.02), previous aminoglycoside use (OR 2.84, 95% CI 1.06-5.14, p = 0.03), and mechanical ventilation (OR 3.26, 95% CI: 2.43-6.15, p = 0.01) as risk factors for infection development. Age (OR 1.16, 95% CI 1.01-1.33, p = 0.03), APACHE 11 score on admission (OR 2.53, 95% CI 1.77-3.41, p = 0.02), SOFA score at the onset of infection (OR 2.88, 95% CI 1.85-4.02, p = 0.02), and VAP (OR 1.32, 95% CI 1.04-1.85, p = 0.03) were associated with mortality. Conclusions: Infections are an important problem in SICUs due to high incidence, multi-drug resistance, complications, and mortality rate. In our study, APACHE II score on admission, peritonitis, acute pancreatitis, previous aminoglycoside use, and mechanical ventilation were identified as risk factors for infection development, whereas age, APACHE II score on admission, SOFA score at the onset of infection, and VAP were associated with mortality. (C) 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 30 条
  • [1] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [2] The international sepsis forum consensus conference on definitions of infection in the intensive care unit
    Calandra, T
    Cohen, J
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (07) : 1538 - 1548
  • [3] Guidelines for the control of glycopeptide-resistant enterococci in hospitals
    Cookson, BD
    Macrae, MB
    Barrett, SP
    Brown, DFJ
    Chadwick, C
    French, GL
    Hateley, P
    Hosein, IK
    Wade, JJ
    [J]. JOURNAL OF HOSPITAL INFECTION, 2006, 62 (01) : 6 - 21
  • [4] A 25-year study of nosocomial bacteremia in an adult intensive care unit
    Edgeworth, JD
    Treacher, DF
    Eykyn, SJ
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (08) : 1421 - 1428
  • [5] Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients - An immediate postmortem histologic study
    ElEbiary, M
    Torres, A
    Fabregas, N
    delaBellacasa, JP
    Gonzalez, J
    Ramirez, J
    delBano, D
    Hernandez, C
    deAnta, MTJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (02) : 583 - 590
  • [6] Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey
    Erbay, H
    Yalcin, AN
    Serin, S
    Turgut, H
    Tomatir, E
    Cetin, B
    Zencir, M
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (09) : 1482 - 1488
  • [7] Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2
    Fridkin, SK
    Steward, CD
    Edwards, JR
    Pryor, ER
    McGowan, JE
    Archibald, LK
    Gaynes, RP
    Tenover, FC
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 245 - 252
  • [8] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [9] Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
    Hanberger, H
    Garcia-Rodriguez, JA
    Gobernado, M
    Goossens, H
    Nilsson, LE
    Struelens, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01): : 67 - 71
  • [10] Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
    Hiramatsu, K
    Aritaka, N
    Hanaki, H
    Kawasaki, S
    Hosoda, Y
    Hori, S
    Fukuchi, Y
    Kobayashi, I
    [J]. LANCET, 1997, 350 (9092) : 1670 - 1673